This review is a summary of a recent speaker event on androgen deprivation therapy (ADT) as the foundation of care in the treatment of prostate cancer.
The presentation was given by Professor David Crawford, Professor of Urology at the University of California and emeritus distinguished endowed Professor of Surgery, Urology, and Radiation Oncology, and Head of the Section of Urologic Oncology at the University of Colorado Anschutz Medical Campus in Aurora, Colorado.
Please login below to download this issue (PDF)